The US Federal Food and Drug Administration, (FDA) is refusing to give a licence to a new weight loss drug until further clinical tests have been carried out. The FDA is worried that Contrave, a new combo medication has been thoroughly evaluated for any cardiovascular risks. Contrave which is manufactured by pharmaceutical company Orexigen contains […]
The Food and Drug Administration the powerful US Quango that controls the licensing of drugs, has ordered a pharmaceutical company to carry out more trials on a new weight loss drug it’s developing. Last October, the FDA rejected the drug Lorcaserin basing its decision on a possibility that the compound is a cancer risk. The […]
The American Society of Plastic Surgeons (ASPS) in collaboration with the Food and Drug Administration (FDA) has created a new registry to compile data on breast implants. The reason for this is to keep an eye on a rare medical condition called Anaplastic Large Cell Lymphoma (ALCL). Although there have only been about 34 cases […]
The U.S. Food and Drug Administration has recently approved only the 2nd trial in the world that will involve using human embryonic stem cells in living patients. The trial is to involved people with Stargardt’s macular dystrophy, a condition that affects the vision of sufferers, who will gradually become blind as their eyesight deteriorates. Christopher […]
At the 18th Annual Scientific Meeting of the International Society of Hair Restoration Surgery (ISHRS), Cytomedix, a top developer of regenerative therapies for inflammation, angiogenesis, and wound care, will soon be showcasing it’s AutoloGel System. The only PRP system with FDA clearance for managing wounds, the AutoloGel System is to be highlighted by Cytomedix in […]
Announcements from the U.S. Food and Drug Administration state that, due to pressure from the FDA, Abbot Laboratories have agreed to withdraw from the U.S market its anti-obesity drug Meridia due to the higher danger of stroke and heart attack. The consumer advocacy group Public Citizen say that the action is long overdue. Dr Sidney […]
Alerts have again been issued by the US Food and Drug Administration (FDA) to orthodontic professionals regarding the risk of patient burns from electric dental handheld devices. The handpieces have left patients requiring reconstructive surgery after experiencing first-degree to third-degree burns after use, but since the FDA’s primary 2007 Public Health Notification, further reports have […]